Lexaria Bioscience Corp. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lexaria Bioscience Corp. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q4 2024.
  • Lexaria Bioscience Corp. Entity Common Stock, Shares Outstanding for the quarter ending January 10, 2025 was 17.6M shares, a 68.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 17.6M +7.12M +68.2% Jan 10, 2025 10-Q 2025-01-10
Q2 2024 15.8M +7.72M +95.4% Jul 12, 2024 10-Q 2024-07-12
Q1 2024 12.9M +6.9M +115% Apr 9, 2024 10-Q 2024-04-09
Q4 2023 10.4M +4.48M +75.4% Jan 12, 2024 10-Q 2024-01-12
Q2 2023 8.09M +2.14M +36% Jul 14, 2023 10-Q 2023-07-14
Q1 2023 5.99M +34.7K +0.58% Apr 14, 2023 10-Q 2023-04-14
Q4 2022 5.95M 0 0% Jan 17, 2023 10-Q/A 2023-01-18
Q2 2022 5.95M +847K +16.6% Jul 13, 2022 10-Q 2022-07-14
Q1 2022 5.95M +847K +16.6% Apr 11, 2022 10-Q 2022-04-11
Q4 2021 5.95M +847K +16.6% Nov 26, 2021 10-Q 2022-01-14
Q2 2021 5.1M -84.5M -94.3% Jul 15, 2021 10-Q 2021-07-15
Q1 2021 5.1M -75.6M -93.7% Apr 13, 2021 10-Q 2021-04-14
Q4 2020 5.1M -75.6M -93.7% Jan 14, 2021 10-Q 2021-01-14
Q3 2020 90M +11.3M +14.3% Oct 14, 2020 10-K 2020-10-15
Q2 2020 89.6M +10.9M +13.9% Jul 2, 2020 10-Q 2020-06-30
Q1 2020 80.7M +2.33M +2.98% Apr 2, 2020 10-Q 2020-04-03
Q4 2019 80.7M +3.27M +4.22% Jan 8, 2020 10-Q 2020-01-09
Q3 2019 78.8M +1.7M +2.2% Nov 5, 2019 10-K 2019-11-14
Q2 2019 78.6M +5.49M +7.51% Jul 8, 2019 10-Q 2019-07-08
Q1 2019 78.4M +6.61M +9.22% Apr 12, 2019 10-Q 2019-04-15
Q4 2018 77.5M +7.13M +10.1% Jan 11, 2019 10-Q 2019-01-11
Q3 2018 77.1M Nov 7, 2018 10-K 2018-11-14
Q2 2018 73.1M +6.17M +9.22% Jul 13, 2018 10-Q 2018-07-13
Q1 2018 71.8M +10.8M +17.6% Apr 11, 2018 10-Q 2018-04-12
Q4 2017 70.3M +15M +27.2% Jan 12, 2018 10-Q 2018-01-12
Q2 2017 67M +21.5M +47.1% Jul 14, 2017 10-Q 2017-07-14
Q1 2017 61M +16.5M +36.9% Apr 14, 2017 10-Q 2017-04-14
Q4 2016 55.3M +10.7M +24.1% Jan 11, 2017 10-Q 2017-01-13
Q2 2016 45.5M +5.58M +14% May 31, 2016 10-Q 2016-07-13
Q1 2016 44.6M +9.87M +28.5% Feb 29, 2016 10-Q 2016-04-13
Q4 2015 44.6M +10.1M +29.3% Dec 22, 2015 10-Q 2016-01-08
Q3 2015 39.9M +5.6M +16.4% Aug 31, 2015 10-K 2015-11-27
Q2 2015 39.9M +7.99M +25% Jul 11, 2015 10-Q 2015-07-14
Q1 2015 34.7M +16.1M +86.7% Mar 23, 2015 10-Q 2015-04-14
Q4 2014 34.4M +17.5M +103% Dec 20, 2014 10-Q 2015-01-14
Q3 2014 34.2M +17.8M +108% Sep 11, 2014 10-Q/A 2014-11-14
Q2 2014 31.9M Jun 11, 2014 10-Q 2014-06-12
Q1 2014 18.6M +2.15M +13.1% Mar 11, 2014 10-Q 2014-03-12
Q4 2013 16.9M +500K +3.04% Jan 24, 2014 10-K 2014-01-24
Q3 2013 16.4M Aug 31, 2013 10-Q 2013-09-10
Q1 2013 16.4M 0 0% Apr 30, 2013 10-Q 2013-06-12
Q4 2012 16.4M 0 0% Jan 29, 2013 10-K 2013-01-29
Q2 2012 16.4M +800K +5.12% Jul 31, 2012 10-Q 2012-09-12
Q1 2012 16.4M Apr 30, 2012 10-Q 2012-06-07
Q4 2011 16.4M Jan 26, 2012 10-K 2012-01-30
Q2 2011 15.6M Jul 31, 2011 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.